Concepedia

Author

Linda R. Weinberg

Avalon Pharma (United States)ORCID

Also Known As

Linda R. Weinberg, Linda Weinberg

12

Publications

233

Citations

8

H-Index

14

Concepts

All Affiliations

Avalon Pharma (United States)
LR

About

Linda R. Weinberg is an author at Avalon Pharma (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

105

2

Natural Sciences

3

3

56

3

Biochemistry

2

2

33

4

Biomolecular Engineering

2

2

49

5

Engineering

1

1

19

Linda R. Weinberg

×

6

Publications

210

Citations

6

H-Index

YearCitations

Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells

Weihua Wan, Mark S. Albom, Lihui Lü,

Blood

2005

105

Synthesis and structure–activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase

Karen L. Milkiewicz, Linda R. Weinberg, Mark S. Albom,

Bioorganic & Medicinal Chemistry

2010

30

Fused bicyclic derivatives of 2,4-diaminopyrimidine as c-Met inhibitors

Linda R. Weinberg, Mark S. Albom, Thelma S. Angeles,

Bioorganic & Medicinal Chemistry Letters

2010

23

2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: Modification of target structure to minimize reactive metabolite formation

Linda R. Weinberg, Mark S. Albom, Thelma S. Angeles,

Bioorganic & Medicinal Chemistry Letters

2011

19

Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases

Craig A. Zificsak, Diane E. Gingrich, Henry J. Breslin,

Bioorganic & Medicinal Chemistry Letters

2011

19

Improvement in oral bioavailability of 2,4-diaminopyrimidine c-Met inhibitors by incorporation of a 3-amidobenzazepin-2-one group

Karen L. Milkiewicz, Lisa D. Aimone, Mark S. Albom,

Bioorganic & Medicinal Chemistry

2011

14

Page 1